Upgrade to SI Premium - Free Trial

After-Hours Stock Movers 09/08: (ABKA) (VTAE) (PLAY) Higher; (TTPH) (ZQK) (FLXN) (PSUN) Lower (more...)

September 8, 2015 5:33 PM
Tetraphase Pharma (NASDAQ: TTPH) 79.5% LOWER; announced that the IGNITE2 phase 3 clinical trial of eravacycline administered as an IV ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles